About Us
AspenBio Pharma, Inc. is an emerging biomedical diagnostic company focused on obtaining U.S. FDA clearance and the European "CE Mark" for its lead product, AppyScore™ which is a unique, blood-based test algorithm designed to help physicians manage the large numbers of patients who enter emergency departments every year complaining of abdominal pain, many of whom are suspected of having acute appendicitis but are at low risk of having the disease. Use of AppyScore™ could potentially improve diagnostic accuracy, reduce healthcare and decrease radiation exposure risk from the use of CT scans routinely performed in diagnosing abdominal pain and appendicitis, which is believed to be particularly more harmful for children, adolescents and young adults. The test is designed to help physicians more easily identify patients who are at low risk for the disease. The company has amassed a large and unique repository of blood samples that may provide valuable information to the discovery process regarding the appendicitis condition and may contain additional protein biomarker information related to other causes of abdominal pain. AspenBio believes the banked samples provide it a leading-edge position for product development.
AspenBio Pharma has several issued or pending patents in the United States and abroad that cover its appendicitis and animal health related technologies.